Harari, Olivier
University of Auckland · St George's, University of London · Regeneron (United States) · The Royal Free Hospital · Auckland City Hospital · University College London
3 papers on CoChatORCID 0000-0001-8214-489X
Most cited papers
- Verified
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., Seitzer, J., O’Connell, D., Walsh, K. R., Wood, K., et al. (2021) · New England Journal of Medicine
Amyloidosis: Diagnosis, Treatment, OutcomesCRISPR and Genetic Engineering
Cited by 1,801
- Verified
Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease
Recio-Mayoral, A., Mason, J. C., Kaski, J. C., Rubens, M. B., Harari, O. A., & Camici, P. G. (2009) · European Heart Journal
Cardiac Imaging and DiagnosticsCardiovascular Function and Risk Factors
Cited by 235
- Verified
Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis.
Isaacs, J. D., Harari, O., Kobold, U., Lee, J. S., & Bernasconi, C. (2013) · Arthritis Research & Therapy
Iron Metabolism and DisordersRheumatoid Arthritis Research and Therapies
Cited by 105
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free